Stocktoria

FATE THERAPEUTICS INC FATE

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2013-10-01 · LEI

FATE THERAPEUTICS INC institutional holders

InvestorSharesValue% of company
BlackRock Finance, Inc.10,116,106$33.2M8.52%
AQR CAPITAL MANAGEMENT LLC3,837,229$10.4M3.23%
TWO SIGMA INVESTMENTS, LP3,589,863$9.7M3.02%
RENAISSANCE TECHNOLOGIES LLC2,983,268$8.1M2.51%
MILLENNIUM MANAGEMENT LLC2,433,978$6.6M2.05%
CITADEL ADVISORS LLC1,093,608$3.0M0.92%
Point72 Asset Management, L.P.442,228$1.2M0.37%

% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.